Home Services Insight Circle Contact
Aluna Healthcare Consulting

Twenty-five years turning healthcare innovation into commercial reality.

Aluna bridges the innovation gap between corporates, startups and investors — applying AI and digital health across diagnostics and the pharma value chain, from biomarker discovery to clinical practice.

25
Years in Healthcare
23
Years at Roche
100
Startups Accelerated
25%
Converted to Partnerships
Scroll
Dr. Jochen Hurlebaus
RoleFounder & President
EducationPhD Bioinformatics · MBA
BasedKüssnacht am Rigi, CH
FocusDiagnostics · AI · Digital Health
Who I Am

Dr. Jochen Hurlebaus, PhD, MBA

"I help healthcare's most promising ideas find their way into the clinic — and their way to the people willing to fund them."

Jochen spent 23 years at Roche Diagnostics, most recently as Head of Digital Health Innovation and previously as Head of Innovation & IP Management — global roles in which he built and led international teams. There he founded Startup Creasphere, Roche's global startup engagement program, which accelerated nearly 100 companies worldwide — roughly a quarter of which advanced into commercial relationships with the corporate.

His grounding in AI runs deeper than strategy: a PhD in Theoretical Biology & Bioinformatics gave him an early computational foundation, which he has since applied to two decades of AI-driven innovation across diagnostics, R&D and digital health.

That depth matters most when others are just repeating buzzwords: Jochen helps investors and corporates look past the AI hype and assess what's actually underneath — model robustness, dependency on third-party APIs, hallucination risk, regulatory compliance and data sovereignty — before capital or partnerships are committed.

He also holds an MSc in Mathematical Ecology from the University of Tennessee, Knoxville, and a dual Executive MBA from the University of Mannheim and ESSEC Paris.

Today, through Aluna Healthcare Consulting, Jochen advises corporates, scale-ups and investors on turning AI and digital health into measurable value — from diagnostics to clinical practice across the pharma value chain.

Also serving as
HealthSeed AG

Venture Partner

Supporting strategic vision, partnership models and end-to-end venture development at the HealthSeed Venture Studio.

healthseed.vc ↗
SkyMedAI

Expert Advisor

C-level advisory and mentorship for companies aiming to thrive in the complex healthcare landscape with AI.

skymedai.com ↗
Aluna Healthcare Consulting

Where corporates, startups and investors meet.

Aluna equips healthcare innovators with the strategic expertise to navigate complex ecosystems, accelerate development and maximize market impact — driving scalable healthcare innovation into clinical use.

01

Diagnostics & MedTech

In-vitro diagnostics, digital diagnostics and algorithms, alongside sensors, wearables and connected devices — the technologies that capture and interpret patient data.

02

Prevention, Care & Longevity

Care-pathway integration and use-case definition that bring innovation into everyday practice — from preventive and predictive health to chronic care and healthy lifespan.

03

Validation & Health Economics

Real-world evidence, clinical validation and health-economic evidence that make the business case for adoption.

Foundational Layer

AI & Digital Health

The algorithms, models and digital infrastructure underpinning every domain above — from clinical decision support and patient-facing digital health tools, to diagnostics interpretation, R&D, operations and commercial applications — with particular depth in evaluating model robustness, regulatory compliance and data strategy.

Before Any Engagement

Three questions worth thinking through on AI.

These aren't a test — they're the starting point I use with every corporate, scale-up and investor I work with, to help clarify where AI actually creates value.

01
"How are you building AI into your product — and how will it define it a year from now?"
Not whether you use AI. Whether it's core to the roadmap, or bolted on.
02
"How could AI make your product obsolete within months? Are you certain it's still needed?"
A useful gut-check — most pitch decks don't cover it, but it's worth having a clear answer.
03
"How are you using AI internally to build a fast, lean, differentiated organization?"
Product AI gets the attention. Organizational AI wins the market.

Few companies have confident answers to all three right away — that's completely normal, and usually where the most useful conversations begin.

Start the conversation
Services & References

Support across the full innovation lifecycle.

From first use case to closed round, Aluna provides end-to-end support — built on a clear strategy, and delivered across technology, partnerships and real-world implementation.

01

Technology & IP Assessment

Due diligence across diagnostics, AI, MedTech and data — including AI model robustness, regulatory compliance and data sovereignty, not limited to any single technology.

02

Partnerships & Deal Structuring

Structuring collaboration between corporates and startups from both sides — licensing, co-development, and equity or milestone-based deals.

03

Implementation & Adoption

From pilots to usability studies, user experience and ROI definition — the evidence that drives real-world adoption, not just a proof of concept.

Foundational Layer

Strategy & Go-to-Market

Where to play and how to win — commercial strategy, use case definition, regulatory pathway and go-to-market design that every other workstream is built on.

For Scale-ups & Startups

From promising to investable

  • Company strategy & competitive positioning
  • Go-to-market design & clinical pathway integration
  • Fundraising — hands-on support raising capital, with introductions to a highly selective investor network, including the Insight Health Private Circle
  • Finding, evaluating & closing strategic partnerships — international deal-making with corporates and investors (IP, equity, milestones)
  • International & European market entry — including regulatory pathway strategy
For Investors, VCs & PE

Confidence before commitment

  • Independent, buy-side technology, AI strategy & scientific due diligence — across diagnostics, digital health and MedTech
  • Commercial & GTM assessment — market strategy and revenue potential, including prevention and longevity opportunities
  • AI model evaluation — architecture strength, "wrapper risk" and hallucination safeguards
  • Regulatory & clinical-safety compliance, plus data sovereignty
  • Proof-of-value project design with providers — including ROI and health-economic modeling
  • Curated deal flow via Insight Health Private Circle
For Corporates

Building the innovation engine

  • Practical AI applications in diagnostics, digital health, MedTech and preventive & longevity care
  • Innovation strategy & operating model design
  • Designing incubation, acceleration & corporate venture-building programs — including venture clienting models
  • Structuring collaboration & deals with startups, scale-ups and investors (IP, equity, milestones)
  • Internal enablement — teaching corporate teams how startups and scale-ups operate and decide
Selected Network & Partners
HealthSeedHealthSeed
SkyMedAISkyMedAI
EyeVisEyeVis
CardiosignalCardiosignal
blueAlphablueAlpha
AyunAyun
Vako.aiVako.ai
bo.lifebo.life
DatosXDatosX
AI DiagnosticsAI Diagnostics
MediqMediq
ClearIPClearIP
NENNEN
QAI VenturesQAI Ventures
yeswetrustyeswetrust
unDavosunDavos

Logos to follow — full reference list available on request.

Contact

Let's talk about your next step.

Turning healthcare innovation into sustainable, commercial reality in the era of AI — for corporates, scale-ups and investors alike.

NameDr. Jochen Hurlebaus, MBA
LocationKüssnacht am Rigi, Switzerland
Send a message